September 04, 2019
WELLESLEY, Mass., Sep 04, 2019–Aging population, improved drug therapy and increasing disease incidence are several factors driving growth in the global pharmacy automation market, according to a report by BCC Research, “Pharmacy Automation: Technologies and Global Markets.”
The market expects to see a compound annual growth rate (CAGR) of 8.6% through 2024, when it could be worth $7.8 billion.
“All market segments of the automation market are expected to show steady, moderate growth ranging between 7% and 15% annually,” writes analyst Melissa Elder. “Sales for all-in-one systems will be a contributor to growth for the market—combining narcotics management with non-narcotics dispensing. Capital equipment purchases increased in the inpatient segment during 2017 and 2018 and are expected to continue to show steady demand. The outpatient market showed some slowing as consolidation halted capital equipment spending for some pharmacy chains, but the market is showing signs of growth in recent months.”
The Need for Safer Systems
There is a recognized need in the medical community, the report adds, for an integrated medication management system capable of running multiple safety checks during the filling of medication and its delivery to patients. These types of systems ensure that the exact medication ordered is delivered to the patient in the correct dosage, administered at the correct time and based on the most up-to-date doctor’s orders.
Editors/reporters requesting analyst interviews should contact Sarah Greenberg at email@example.com.
Pharmacy Automation: Technologies and Global Markets( IAS026F )
Data and analysis extracted from this press release must be accompanied by a statement identifying BCC Research LLC as the source and publisher. For media inquiries, email firstname.lastname@example.org or visit www.bccresearch.com/media to request access to our library of market research.